• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

CV Reps Need to start selling something?

Quote
Anonymous said:
At the risk of sounding like a parrot, 21% R.R.R., 2.1% absolute risk reduction on top of asprirn, beta blocker, ace inhibitor, heparin, etc. in reducing the risk of m.i., stroke and vascular death w or w/o stenting in acute coronary syndrome is a therapeutic advancement.
Stay on the B.I. site dumb ass!
Click to expand...

ASSHOLE. NUMBER NEEDED TO TREAT WOULD NOT HAVE SUPPORTED USING PLAVIX W/O STENT. CAPRIE WOULD HAVE KJLLED ACS EVEN THOUGH PATIENTS WERE NOT ACS. TAKE YOUR 2% ABSOLUTE WITH ACS W\O STENT AND DRINK KOOL AID. YOU ARE A IDIOT
 












Anonymous said:
ASSHOLE. NUMBER NEEDED TO TREAT WOULD NOT HAVE SUPPORTED USING PLAVIX W/O STENT. CAPRIE WOULD HAVE KJLLED ACS EVEN THOUGH PATIENTS WERE NOT ACS. TAKE YOUR 2% ABSOLUTE WITH ACS W\O STENT AND DRINK KOOL AID. YOU ARE A IDIOT
Click to expand...

Yeah, it would have idiot. The study was conducted in multiple sites in multiple countries in a time when the rush to perform cardiac stenting was minimal, even here in the U.S. The clinical study was CARE. Check your facts with your ego you venom spewing B.I. troll!
 












After all these years, why should we start now? Plavix sold itself in my geography, I just spent my money and dropped samples. Didn't message a single doc unless I had company with me.

CV is cake, we aren't doing jack sh it and getting PAID.
 
































Anonymous said:
CV Reps Need to start selling something?

Why start now.

Never had to before.

For years, Stenting drove all the Plavix business and dropping samples got them in the office to check boxes on calls.

The goal was to find a new product with the same sort of profile. It worked before no need to fix what isn't broken.
Click to expand...

Since when did Bristol ever sample plavix? Thank your Sanofirep for carrying you since 2001.
 




Anonymous said:
Since when did Bristol ever sample plavix? Thank your Sanofirep for carrying you since 2001.
Click to expand...

Samples ain't sellin' and CV hasn't had to sell uphill since the ACC/AHA guidelines came out and Sanofi never has. However, even then it was no walk in the park. The diabetes team has been selling uphill over a hundred miles of bad road since Metaglip, but that is still no reason to bad mouth CV. Both teams had better band together soon because you will most likely end up as the same team in the near future.
 




They get 100% to do nothing while Diabetes reps who are out working their tails off for share may wind up with 50%. What a farce. Like it'd be that hard for CV to sell Onglyza for 6 months.
 




Anonymous said:
They get 100% to do nothing while Diabetes reps who are out working their tails off for share may wind up with 50%. What a farce. Like it'd be that hard for CV to sell Onglyza for 6 months.
Click to expand...

Stop whining, we deserve 100% payout because we are the original specialists. If we had not sold Ong/KOMBI, you guys would be even lower than you are. Onglyza is your baby now, think you can handle it?
 




Top Bottom
Back
Quote